NEW YORK–(BUSINESS WIRE)–RubiconMD, the leading multi-specialty care platform, is proud to announce its sponsorship of two national events this spring: the National Commission on Correctional Health Care (NCCHC)’s Spring Conference on Correctional Health Care and the Association of Physician Groups (APG) Annual Conference. The Spring Conference on Correctional Health Care takes place from April 29 … [Read more…]
— Cytokine-induced memory-like (CIML) NK cells engaged and activated endogenous adaptive immunity in the tumor microenvironment (TME) — — WU-NK-101 demonstrated PD-L1 and MHC-I checkpoint upregulation in solid tumor models — — Data highlight the potential of WU-NK-101 to reverse primary and acquired mechanisms of immune checkpoint blockade (ICB) resistance — ST. LOUIS & SAN … [Read more…]
Data showcased the mechanism of action, design, and delivery of NTX-250 in preclinical studies Coupling cell signaling components with local delivery of NTX-250 resulted in robust anti-tumor activity, as evidenced in murine models Collaborative study between Nutcracker Therapeutics and the research groups at UCSF presented as late-breaking oral abstract EMERYVILLE, Calif.–(BUSINESS WIRE)–Nutcracker Therapeutics, Inc., a … [Read more…]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the company will be hosting an investor education webcast in conjunction with Canaccord Genuity, focusing on Cryo Nerve Block Therapy. The company also announced that … [Read more…]
Experienced Life Sciences Executive Brings 15 Years of Legal, Corporate Strategy, and Business Development Experience BURLINGTON, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced the appointment of Stephen Migausky as Senior Vice President … [Read more…]
BOSTON & LEIDEN, Netherlands–(BUSINESS WIRE)–Leyden Laboratories B.V., (the “Company” or “Leyden Labs”) announced today the dosing of the first Phase 1 healthy volunteer cohort with a nasal spray containing PanFlu candidate CR9114. CR9114 is a universal anti-hemagglutinin stem human antibody which has been shown to provide broad protection in animal studies against influenza infection and … [Read more…]
Rapid blood test sensitive to advanced adenomas could improve patient prognosis and ultimately reduce mortality ORLANDO, Fla.–(BUSINESS WIRE)–Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today presented new data in a presentation titled “Early Detection and Molecular Markers of Prevention” on the detection of colorectal cancer … [Read more…]
BOSTON–(BUSINESS WIRE)–Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema (HAE) and focused on life-changing therapies for rare and niche allergic and immunological diseases, announced today that it has promoted Andrea Matthews to Chief Business Officer. Ms. Matthews brings 20 years of business experience to the role and has … [Read more…]
Data Highlights the Value of HeartCare and AlloSure Lung in Clinical Practice Leading Experts Present Latest Advancements in Heart and Lung Transplantation During CareDx Symposia BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – … [Read more…]
Industry veteran to drive next phase of growth as company unveils updated brand identity and newly launched website BALA CYNWYD, Pa.–(BUSINESS WIRE)–Ardelis Health, a healthcare strategic marketing agency and consulting firm partnering with innovators that discover, differentiate, and launch important therapies, today announced the appointment of industry veteran Timmy Garde as Chief Growth Officer. “We … [Read more…]
